titlesubmit dateissue date
Now showing items 1-18 of 18
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Combined associations of a polygenic risk score and classical risk factors with breast cancer risk
Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis.
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk
Shared heritability and functional enrichment across six solid cancers
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.